# FDA Approval of Inhaled Insulin Offers New Option for Young People With Diabetes
The FDA approval of inhaled insulin represents a meaningful shift in diabetes management for adolescents and young adults who struggle with needle anxiety or injection compliance. Taisie Siegrist, a teenager with type 1 diabetes, experienced this change firsthand after switching from traditional injected insulin to Afrezza, an inhaled powder formulation.
Inhaled insulin works by delivering rapid-acting insulin directly into the lungs, where it absorbs quickly into the bloodstream. This method bypasses needles entirely, addressing a barrier that affects many young people's willingness to take insulin consistently. For Taisie, the shift meant reduced anxiety around mealtimes and greater independence in managing her condition without drawing attention in social settings.
The approval carries clinical backing. Inhaled insulin demonstrates comparable efficacy to injected rapid-acting insulin in controlling blood sugar levels, with onset times that support mealtime dosing. However, it does come with considerations. Inhaled insulin requires careful technique to ensure proper lung delivery, and it's contraindicated for people with underlying lung disease like asthma or COPD. Patients typically need baseline and periodic lung function tests.
Healthcare providers emphasize that inhaled insulin works best as part of a comprehensive diabetes management plan that includes basal insulin or long-acting insulin alternatives, blood glucose monitoring, and lifestyle adjustments. For some young people, the psychological benefit of needle-free administration substantially improves treatment adherence, which directly impacts long-term diabetes control and health outcomes.
The development reflects a broader movement toward diversifying insulin delivery methods. Rather than replacing traditional injections, inhaled insulin expands options for patients whose preferences or circumstances make it suitable. Parents and teens considering this option should discuss lung function screening, technique training, and insurance coverage with their endocrinology team